TB Research

biofilms: mechanism of production, composition, and its role in pathogenesis and drug resistance.

William R McManus, Katie Mulvey, Jeffrey S Schorey

Critical reviews in microbiology · 2026-05

Abstract

The genuscontains over 180 species, and new species are added frequently. Among these are several obligate pathogens, namelyand the species of thecomplex; however, the vast majority are environmental bacteria that occupy numerous habitats and are collectively referred to as nontuberculous mycobacteria (NTM). Most NTM are harmless to humans, but the ability of some species to cause infections in people has been increasingly recognized over the past several decades.subs.has emerged as one of the most common opportunistic pathogens, usually causing pulmonary infections in susceptible people following environmental exposure.'s ability to form biofilms is key to its survival in environments that place it in close proximity to susceptible populations. Their capacity to form biofilmsmay also be an important aspect of their pathogenesis and known antibiotic resistance. In this review, we discuss the pathogenesis of this important mycobacterial species, what we know of its ability to form biofilmsandand gaps in our knowledge of these processes. We also discuss how we may leverage our understanding of molecules involved in biofilm formation and biofilm matrix composition to develop new therapeutics targeting biofilm formation.

MeSH terms

  • Biofilms
  • Humans
  • Mycobacterium avium
  • Drug Resistance, Bacterial
  • Animals
  • Anti-Bacterial Agents